Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »
Text size Justin Sullivan / Getty Images Coca-Cola shares are rising early Wednesday morning, a day after launching better-than-expected earnings. The reason: An update from Morgan Stanley, which argues that stocks have become too cheap. Analyst Dara Mohsenian raised its rating on Coca-Cola (ticker: KO) shares to Equal Weight’s Overweight, …
Read More »
Coca-Cola Co. says it will streamline its portfolio, cutting what it calls “zombie brands” to focus on more successful brands and smaller names with potential. According to James Quincey, CEO of Coca-Cola KO, + 2.34% Many of the company’s 400 “master brands” are located in one country and represent only …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »